ZYTOX THERAPEUTICS
Zytox Therapeutics develops protein-based drugs for cancer treatment.
Similar Organizations
ARTyx
ARTyx helps in developing an avant-garde RNA therapeutic platform for cancer treatment With a preliminary focus on breast cancer.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
BAKX Therapeutics
BAKX Therapeutics is a provider of cancer treatment.
Bionetix Therapeutics
Bionetix Therapeutics is a developer of anticancer drugs designed for cancer treatment.
Centizyme
Centizyme develops a nanoparticle-based treatment for severe asthma.
Chimeros
Chimeros develops therapies for cancer treatment.
Compass Cancer Center
Compass Cancer Center provides medicine services for cancer treatment.
Invictus Oncology
Invictus Oncology develops therapeutics for cancer treatment.
Saphtx
Saphtx develops protein-based therapeutic strategies for a wide range of diseases.
Investors List
KTH Holding
KTH Holding investment in Venture Round - Zytox Therapeutics
More informations about "Zytox Therapeutics"
Zytox Therapeutics - KTH Holding AB
Zytox Therapeutics. Based on leading research at KTH and Uppsala University Zytox Therapeutics develops protein-based tumor targeting. INVESTMENT 2021. WEBB. STATUS …See details»
Zytox Therapeutics - PitchBook
Marianne Hansson is the CEO of Zytox Therapeutics. Where is Zytox Therapeutics headquartered? Zytox Therapeutics is headquartered in Johanneshov, Sweden. What industry …See details»
Zytox Therapeutics - Funding, Financials, Valuation & Investors
Zytox Therapeutics develops protein-based drugs for cancer treatment. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. ... How …See details»
Zytox Therapeutics AB - Drug pipelines, Patents, Clinical trials
Explore Zytox Therapeutics AB with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Neoplasms, Technology Platform:Fusion protein, Drug:WO2023148388. ...See details»
Zytox Therapeutics - KTH Holding AB
Zytox Therapeutics. Baserat på mångårig forskning vid KTH och Uppsala Universitet utvecklar Zytox Therapeutics proteinbaserade läkemedel för cancerbehandling. INVESTERING 2021. …See details»
Venture Round - Zytox Therapeutics - 2021-01-01 - Crunchbase
Jan 1, 2021 Venture Round - Zytox Therapeutics . Save . Summary. Overview. Edit Overview Section. Organization Name . Zytox Therapeutics . Announced Date Jan 1, 2021; Funding …See details»
Zytox Therapeutics AB Company Profile - Dun & Bradstreet
Zytox Therapeutics AB Company Profile | Johanneshov, Stockholm, Sweden | Competitors, Financials & Contacts - Dun & BradstreetSee details»
Zytox Therapeutics (company) - Nordic 9
Zytox Therapeutics is a health startup from Sweden developing protein-based tumor targeting. Investors: we tracked 1 investor You need an account to access this feature.See details»
WO2023148388 - Drug Targets, Indications, Patents - Synapse
WO2023148388, Initially developed by Zytox Therapeutics AB, Now, its global highest R&D status is Discovery, Therapeutic Areas: Neoplasms, Active Indication: Neoplasms, Active Org.: Zytox …See details»
Short CV | Stefan Ståhl - KTH
Member of the Board of Directors for: Intervacc AB, public 2017 on Nasdaq - First North (2009-2023), Amylonix AB (2018-present; chairman of the board), KTH Holding AB (2013-present; …See details»
Zytox Therapeutics, Stockholm, SE | Company Information
Zytox Therapeutics. No ratings. Blåsutvägen 13 12136 Stockholm Stockholms Län - Sweden. Centre For Industrial Research. Interested in this type of business for your B2B prospection? …See details»
Marianne Hansson – Zytox Therapeutics AB | LinkedIn
Erfarenhet: Zytox Therapeutics AB · Plats: Greater Stockholm Metropolitan Area · 486 kontakter på LinkedIn. Visa Marianne Hanssons profil på LinkedIn, ett yrkesnätverk med 1 miljard …See details»
Sumitovant Biopharma Announces Myovant Sciences and Pfizer …
Dec 28, 2020 Sumitovant is the majority shareholder of Myovant Sciences and Urovant Sciences, and wholly owns Enzyvant Therapeutics, Spirovant Sciences, and Altavant …See details»
Zytox Therapeutics - Crunchbase
Zytox Therapeutics develops protein-based drugs for cancer treatment.See details»
Silo Pharma (SILO) and Zylo Therapeutics, Inc. (ZTI) enter ... - Nasdaq
--Silo Pharma, Inc. a developmental stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, today announced that it has entered into a Joint Venture with …See details»
Cannabis firm exploring plant-based tech with VIDO-InterVac
May 12, 2020 Saskatoon's Zyus Life Sciences is working in collaboration with the Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac) to develop and …See details»
Centre for Digital Therapeutics - Crunchbase
Centre for Digital Therapeutics is a health care center that provides digital therapeutics and m-health services. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. …See details»
Cytomx Therapeutics - Overview, News & Similar companies
Aug 12, 2024 CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024 SOUTH SAN FRANCISCO, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- CytomX …See details»
Cytox - Crunchbase Company Profile & Funding
International initiatives underway to find treatments with many drugs in clinical development. Cytox are commercially launching their tests in conjunction with Affymetrix (part of Thermo …See details»